Details for New Drug Application (NDA): 209085
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 209085
Tradename: | PEMETREXED DISODIUM |
Applicant: | Apotex |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 209085
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 209085
Suppliers and Packaging for NDA: 209085
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 209085 | ANDA | Apotex Corp | 60505-6067 | 60505-6067-0 | 1 VIAL in 1 CARTON (60505-6067-0) / 40 mL in 1 VIAL |
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 209085 | ANDA | BluePoint Laboratories | 68001-546 | 68001-546-41 | 1 VIAL in 1 CARTON (68001-546-41) / 40 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | May 25, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription